These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21865342)

  • 1. Impaired FcεRI stability, signaling, and effector functions in murine mast cells lacking glycosylphosphatidylinositol-anchored proteins.
    Hazenbos WL; Wu P; Eastham-Anderson J; Kinoshita T; Brown EJ
    Blood; 2011 Oct; 118(16):4377-83. PubMed ID: 21865342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell Activation.
    Abdala-Valencia H; Bryce PJ; Schleimer RP; Wechsler JB; Loffredo LF; Cook-Mills JM; Hsu CL; Berdnikovs S
    J Immunol; 2015 Aug; 195(4):1377-87. PubMed ID: 26136426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI.
    Xiao W; Nishimoto H; Hong H; Kitaura J; Nunomura S; Maeda-Yamamoto M; Kawakami Y; Lowell CA; Ra C; Kawakami T
    J Immunol; 2005 Nov; 175(10):6885-92. PubMed ID: 16272347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirtuin 6 is a negative regulator of FcεRI signaling and anaphylactic responses.
    Jang HY; Ha DH; Rah SY; Lee DH; Lee SM; Park BH
    J Allergy Clin Immunol; 2022 Jan; 149(1):156-167.e7. PubMed ID: 34051221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SWAP-70 regulates mast cell FcepsilonRI-mediated signaling and anaphylaxis.
    Sivalenka RR; Sinha M; Jessberger R
    Eur J Immunol; 2008 Mar; 38(3):841-54. PubMed ID: 18236401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
    Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
    Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Src family kinase Fgr is critical for activation of mast cells and IgE-mediated anaphylaxis in mice.
    Lee JH; Kim JW; Kim DK; Kim HS; Park HJ; Park DK; Kim AR; Kim B; Beaven MA; Park KL; Kim YM; Choi WS
    J Immunol; 2011 Aug; 187(4):1807-15. PubMed ID: 21746961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoskeletal Protein 4.1R Is a Positive Regulator of the FcεRI Signaling and Chemotaxis in Mast Cells.
    Draberova L; Draberova H; Potuckova L; Halova I; Bambouskova M; Mohandas N; Draber P
    Front Immunol; 2019; 10():3068. PubMed ID: 31993060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses.
    Akimoto M; Mishra K; Lim KT; Tani N; Hisanaga SI; Katagiri T; Elson A; Mizuno K; Yakura H
    Scand J Immunol; 2009 May; 69(5):401-11. PubMed ID: 19508371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The scaffold protein prohibitin is required for antigen-stimulated signaling in mast cells.
    Kim DK; Kim HS; Kim AR; Jang GH; Kim HW; Park YH; Kim B; Park YM; Beaven MA; Kim YM; Choi WS
    Sci Signal; 2013 Sep; 6(292):ra80. PubMed ID: 24023254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine receptor H4 regulates mast cell degranulation and IgE induced FcεRI upregulation in murine bone marrow-derived mast cells.
    Mirzahosseini A; Dalmadi B; Csutora P
    Cell Immunol; 2013; 283(1-2):38-44. PubMed ID: 23850674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the FcepsilonRI beta-chain ITAM as a signal regulator for mast cell activation with monomeric IgE.
    Nunomura S; Gon Y; Yoshimaru T; Suzuki Y; Nishimoto H; Kawakami T; Ra C
    Int Immunol; 2005 Jun; 17(6):685-94. PubMed ID: 15944196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTPalpha activates Lyn and Fyn and suppresses Hck to negatively regulate FcepsilonRI-dependent mast cell activation and allergic responses.
    Samayawardhena LA; Pallen CJ
    J Immunol; 2010 Nov; 185(10):5993-6002. PubMed ID: 20944008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine hemokinin-1 functions as an endogenous adjuvant for IgE-mediated mast cell inflammatory responses.
    Sumpter TL; Ho CH; Pleet AR; Tkacheva OA; Shufesky WJ; Rojas-Canales DM; Morelli AE; Larregina AT
    J Allergy Clin Immunol; 2015 Apr; 135(4):1019-1030.e8. PubMed ID: 25201259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLAP Is a Negative Regulator of FcεRI Receptor-Mediated Signaling and Allergic Response.
    Sharma N; Ponce M; Kaul S; Pan Z; Berry DM; Eiwegger T; McGlade CJ
    Front Immunol; 2019; 10():1020. PubMed ID: 31156621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.
    Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA
    Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Src family kinases in mast cell effector function.
    Furumoto Y; Gomez G; Gonzalez-Espinosa C; Kovarova M; Odom S; Ryan JJ; Rivera J
    Novartis Found Symp; 2005; 271():39-47; discussion 47-53, 95-9. PubMed ID: 16605127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Src family kinase Hck regulates mast cell activation by suppressing an inhibitory Src family kinase Lyn.
    Hong H; Kitaura J; Xiao W; Horejsi V; Ra C; Lowell CA; Kawakami Y; Kawakami T
    Blood; 2007 Oct; 110(7):2511-9. PubMed ID: 17513616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SG-SP1 Suppresses Mast Cell-Mediated Allergic Inflammation via Inhibition of FcεRI Signaling.
    Kim MJ; Je IG; Song J; Fei X; Lee S; Yang H; Kang W; Jang YH; Seo SY; Kim SH
    Front Immunol; 2020; 11():50. PubMed ID: 32063904
    [No Abstract]   [Full Text] [Related]  

  • 20. Nanoparticles Displaying Allergen and Siglec-8 Ligands Suppress IgE-FcεRI-Mediated Anaphylaxis and Desensitize Mast Cells to Subsequent Antigen Challenge.
    Duan S; Arlian BM; Nycholat CM; Wei Y; Tateno H; Smith SA; Macauley MS; Zhu Z; Bochner BS; Paulson JC
    J Immunol; 2021 May; 206(10):2290-2300. PubMed ID: 33911007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.